Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Medizinische Klinik mit Schwerpunkt Nephrologie, Hindenburgdamm 30, D-12203 Berlin, Germany.
Curr Pharm Des. 2010 May;16(13):1468-79. doi: 10.2174/138161210791050979.
Atherosclerosis is the major cause of cardiovascular morbidity and mortality. A multitude of pro-atherogenic mediators are known liable for the initiation and progression of atherogenic vascular lesions. Only few endogenous molecules are known so far with cardiovascular protective properties, whereas high-density lipoprotein (HDL) is one of the most important. Beside cholesterol efflux, many pleiotropic cell-mediated functions of HDL are known so far. HDL is a spherical particle that contains different proteins and lipids. Especially sphingolipids, like sphingosine-1-phosphate (S1P), has gained great attention. The HDL associated S1P seems to be responsible for many of the pleiotropic effects of HDL by activating special S1P receptors. This review focuses on HDL associated sphingolipids as mediators of known protective pleiotropic effects of HDL and their possible therapeutic relevance.
动脉粥样硬化是心血管发病率和死亡率的主要原因。已知多种促动脉粥样硬化介质易引发动脉粥样硬化血管病变的发生和进展。目前仅发现少数具有心血管保护特性的内源性分子,而高密度脂蛋白 (HDL) 就是其中之一。除了胆固醇外排,目前已知 HDL 具有许多多效性的细胞介导功能。HDL 是一种球形颗粒,包含不同的蛋白质和脂质。特别是鞘脂,如鞘氨醇-1-磷酸 (S1P),已引起广泛关注。与 HDL 相关的 S1P 似乎通过激活特殊的 S1P 受体,对 HDL 的许多多效性作用负责。这篇综述重点介绍与 HDL 相关的鞘脂作为 HDL 已知的保护多效性作用的介质及其可能的治疗相关性。